BALANSEAT RCT study on seated balance training with the Balanseat device in older people

Completed

Conditions: Gerontologie, ouderdoms gerelateerde mobiliteits/balans problemen
balance and gait

Registration Number: NL-OMON52787

Lead Sponsor: Hanzehogeschool

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 88

Inclusion Criteria

• Age 65+ years
• Ability to walk at least 10 meters on a *at surface, with or without an
assistive device
• Decreased walking speed; gait speed < 0.8 m/sec, during walk test
• An informed consent was signed by the participant

Exclusion Criteria

• Individuals with a major disease or unstable health that prevents their
participation
• Individuals with amputees or who had surgery in the past three months
• Individuals following physical therapy related to back, walking and/or
balance problems
• Individuals with MCI or dementia

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- Therapy adherence; Adherence to the intervention will be assessed based on<br /><br>adherence to the balanseat program during the study. Adherence to the balanseat<br /><br>program will be calculated based on completion of exercise bouts.<br /><br>- Gait and balance parameters to be measured before, during (after 6 sessions)<br /><br>and after the intervention (post 12 sessions) include; timed up and go (TUG),<br /><br>10 meter walk test (10MWT), short physical performance battery (SPPB),<br /><br>functional reach test (FRT) and Falls efficacy scale (FES). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>General mobility, quality and quantity of walking and quality and quantity of<br /><br>chair rises measured with the GoSafe device. One week before the Balanseat<br /><br>intervention, participants from the intervention group will start wearing the<br /><br>GoSafe device to enable a reliable measure of the pre-intervention phase.<br /><br>Participants will continue wearing the GoSafe device throughout the<br /><br>intervention period, and until one week after the intervention period, to<br /><br>enable a reliable measure of the post-intervention phase. The control group<br /><br>will undergo the same assessments and wear the GoSafe device the same amount of<br /><br>time compared to the intervention group. </p><br>